MetLife Inc (MET) stock analysis
Close on Nov 11, 2026Market cap $65.42BP/E 13.4Yield 2.18%
StockData Score
Prices as of Nov 11, 2026How the score works
Mixed10 of 30 checks passed
MetLife passes 10 of the 30 checks behind our score; 6 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 1/6
- Growth
- 2/6
- Past performance
- 2/6
- Financial health
- 2/6
- Dividend
- 3/6
What stands out
Low debt
Debt is 1.3% of shareholders' equity, under the 40% we consider low.
Earnings growth accelerating
Net income grew 33.5% over the last twelve months, against a 5-year average of -9.0% a year.
Debt covered by cash flow
Operating cash flow over the last twelve months equals 4841% of total debt.
P/E below its 5-year median
MetLife's P/E of 13.4 is below its own 5-year median of 14.4.
What to watch
Margin of safety under 20%
The price is 39.2% above fair value, so there is no margin of safety.
Trading above fair value
The share price of $102.94 is above our fair value estimate of $73.93.
Return on equity under 15%
Return on equity was 20.0% over the last twelve months and averaged 10.7% over five years; we look for 15% on both.
Earnings shrank over 5 years
Net income shrank 9.0% a year on average over the last five fiscal years.
Valuation1/6
P/E below its 5-year median
MetLife's P/E of 13.4 is below its own 5-year median of 14.4.
P/E above the industry
MetLife's P/E of 13.4 is above the Life Insurance median of 10.8.
P/S above the industry
MetLife's price-to-sales of 0.79 is above the Life Insurance median of 0.67.
P/B above the industry
MetLife's price-to-book of 2.94 is above the Life Insurance median of 1.11.
Trading above fair value
The share price of $102.94 is above our fair value estimate of $73.93.
Margin of safety under 20%
The price is 39.2% above fair value, so there is no margin of safety.
Growth2/6
Revenue growing under 10% a year
Revenue grew 3.9% a year over the last three fiscal years, short of the 10% we look for.
EPS growing under 10% a year
Diluted EPS grew -9.2% a year over the last three fiscal years.
Earnings growth accelerating
Net income grew 33.5% over the last twelve months, against a 5-year average of -9.0% a year.
Growing faster than the industry
Revenue grew 14.8% over the last twelve months; the Life Insurance median is 7.1%.
Company guidance
No outlook found in earnings releases from the last twelve months.
Gross margin trend
Banks and insurers do not report gross profit.
Past performance2/6
Return on equity under 15%
Return on equity was 20.0% over the last twelve months and averaged 10.7% over five years; we look for 15% on both.
Return on assets under 1%
Return on assets was 0.7%; for a bank or insurer, 1% or more is considered good.
Return on equity above the industry
MetLife's return on equity of 20.0% is above the Life Insurance median of 12.6%.
Earnings shrank over 5 years
Net income shrank 9.0% a year on average over the last five fiscal years.
Net margin above its 5-year average
Net margin was 6.2% over the last twelve months, against a 5-year average of 6.1%.
Net margin below the industry
MetLife's net margin of 6.2% is below the Life Insurance median of 8.1%.
Financial health2/6
Low debt
Debt is 1.3% of shareholders' equity, under the 40% we consider low.
Debt rising against equity
Debt to equity rose from 0.5% five years ago to 1.3%.
Debt covered by cash flow
Operating cash flow over the last twelve months equals 4841% of total debt.
Interest coverage
Interest expense is not reported separately.
Short-term liquidity
Insurers do not split assets into current and non-current.
Bankruptcy risk (Altman Z)
The Altman model does not apply to insurers.
Dividend3/6
Pays a dividend
MetLife paid dividends worth 1.7% of the share price over the last twelve months.
Yield below Treasuries
The 1.7% yield is below the 4.4% on a 1-year Treasury.
Yield below the top quarter
The top quarter of US dividend payers yield 3.8% or more; MetLife yields 1.7%.
Dividend not cut
The dividend per share has not fallen by more than 10% in any of the last 10 fiscal years.
Covered by earnings
Dividends take 29.4% of net income.
Cash-flow cover
Needs dividends paid and free cash flow.
Fair value
How we estimate itOur estimate per share
$73.93
The share price is 39% above this estimate.
| Method | Multiple used | Own 5Y median | Industry median | Value per share | Weight |
|---|---|---|---|---|---|
| P/E | 12.6× | 14.4× | 10.8× | $96.66 | 50% |
| P/B | 1.5× | 1.8× | 1.1× | $51.19 | 50% |
| Fair value | $73.93 | 100% | |||
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Own 5-year median 14.4
- Life Insurance median 10.8
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Low risk
- Average value traded per day
- $325.47M
- Value traded per 1% price move
- $277.69M
Downside
Low risk
- Typical loss in a bad month
- 11.1%
- Volatility (annualized)
- 24%
- Sharpe ratio, 1 year
- 1.21
- Beta to the S&P 500 (5Y)
- 0.87
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2011 to 2025
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +8.6% | +3.9% | +2.6% | +2.3% | |
| Operating income | +2.4% | +0.9% | – | – | |
| Net income | -23.7% | -13.8% | -9.0% | -4.5% | |
| EPS, diluted | -20.7% | -9.2% | -3.7% | +0.2% | |
| Dividend per share | +4.3% | +4.3% | +4.3% | +4.3% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 1.3% | 7.7% | 12.1% | |
| Return on assets | 0.1% | 0.7% | 0.5% | |
| Interest coverage | – | – | 8.5× | |
| Diluted shares | 1.11B | 913M | 673M |
Cash use needs five years of cash flow figures
MetLife does not report operating cash flow and capital expenditure for each of the last five fiscal years.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 4.4% | 0.11× | 25.48× | 12.1% |
| FY2024 | 6.2% | 0.10× | 23.76× | 15.4% |
| FY2023 | 2.4% | 0.10× | 22.55× | 5.3% |
| FY2022 | 7.7% | 0.10× | 14.61× | 10.9% |
| FY2021 | 10.0% | 0.09× | 10.95× | 9.7% |
| FY2020 | 8.0% | 0.09× | 10.91× | 7.7% |
| FY2019 | 8.5% | 0.10× | 12.01× | 9.9% |
| FY2018 | 7.5% | 0.10× | 12.63× | 9.2% |
| FY2017 | 6.4% | 0.08× | 12.83× | 6.4% |
| FY2016 | 1.4% | 0.07× | 13.10× | 1.3% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero$3.38B
- Cash generatingOperating cash flow above zero$17.09B
- Return on assets improvedROA up on the prior year0.6% → 0.5%
- Earnings backed by cashOperating cash flow above net income$17.09B vs $3.38B
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose– → –
- No dilutionShare count did not rise711M → 673M
- Gross margin improvedGross margin up on the prior year– → –
- More efficientAsset turnover rose0.10 → 0.11
See a number that looks wrong?